Latest Blog: 30th April 2019
What drives the stand out success of genomics biotech pioneer, Congenica?
Amadeus-backed biotech Congenica has raised over £23m in its latest round . The genomics revolution has spawned thousands of start-ups. Why has Congenica flourished where others have failed to make it? It comes down to three things – the management team, a relentless focus on commercialisation and continuous innovation. Genomic medicine is a combination of advanced [...]
Blog: 1st April 2019
Evolving investments in gene technology
Genetic science and the creation of large genomic databases have opened up the possibilities for personalised medicine as never before. Amadeus has been investing in this space since the early days, when in 2001 we backed Solexa (now Illumina ), the market leader in genetic testing equipment. Solexa’s low-cost technology was fundamental in enabling [...]